INVITRO GENETICS LIMITED

Active Fareham

Specialists medical practice activities

27 employees website.com
Specialists medical practice activities
I

INVITRO GENETICS LIMITED

Specialists medical practice activities

Founded 3 Dec 2015 Active Fareham, United Kingdom 27 employees website.com
Specialists medical practice activities
Accounts Submitted 1 Aug 2025 Next due 31 Jul 2026 1 month remaining
Confirmation Submitted 8 Jul 2025 Next due 15 Jul 2026 1 month remaining
Net assets £289K £278K 2024 year on year
Total assets £3M £833K 2024 year on year
Total Liabilities £3M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Delta Park Concorde Way Segensworth North Fareham Hampshire PO15 5RL United Kingdom

Full company profile for INVITRO GENETICS LIMITED (09901425), an active company based in Fareham, United Kingdom. Incorporated 3 Dec 2015. Specialists medical practice activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Nov → 31 Oct 2024
Type full
Next accounts 31 Oct 2025
Due by 31 Jul 2026 1 month remaining

Balance Sheet & P&L (2016–2024)

Cash in Bank

£529.84k

Decreased by £789.97k (-60%)

Net Assets

£288.84k

Increased by £277.77k (+2511%)

Total Liabilities

£3.00M

Decreased by £1.11M (-27%)

Turnover

£7.47M

Increased by £578.38k (+8%)

Employees

27

Debt Ratio

91%

Decreased by 9 (-9%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Oct Year End
2023
31 Oct Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 3 Shares £6.83m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Sept 20181£300k£300k
30 Apr 20181£6.53m£6.53m
31 Oct 20161£1£1

Officers

Officers

1 active 2 resigned
Status
Brian George AndrewsDirectorAmericanUnited States488 Aug 2018Active

Shareholders

Shareholders (1)

Coopersurgical Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

INVITRO GENETICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Aug 2025AccountsAnnual accounts made up to 31 Oct 2024
8 Jul 2025Confirmation StatementConfirmation statement made on 1 Jul 2025 with no updates
1 Jul 2025OfficersChange to director Mr Agostino Ricupati on 1 Jun 2025
18 Mar 2025OfficersChange to director Mr Agostino Ricupati on 15 May 2023
5 Feb 2025OfficersTermination of John Joseph Calcagno as director on 5 Feb 2025
1 Aug 2025 Accounts

Annual accounts made up to 31 Oct 2024

8 Jul 2025 Confirmation Statement

Confirmation statement made on 1 Jul 2025 with no updates

1 Jul 2025 Officers

Change to director Mr Agostino Ricupati on 1 Jun 2025

18 Mar 2025 Officers

Change to director Mr Agostino Ricupati on 15 May 2023

5 Feb 2025 Officers

Termination of John Joseph Calcagno as director on 5 Feb 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Oct 2024

10 months ago on 1 Aug 2025

Confirmation statement made on 1 Jul 2025 with no updates

11 months ago on 8 Jul 2025

Change to director Mr Agostino Ricupati on 1 Jun 2025

11 months ago on 1 Jul 2025

Change to director Mr Agostino Ricupati on 15 May 2023

1 years ago on 18 Mar 2025

Termination of John Joseph Calcagno as director on 5 Feb 2025

1 years ago on 5 Feb 2025